ORIC Pharmaceuticals Stock (NASDAQ: ORIC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 169.00 / 595.39K |
Day Range | - - - |
52 Wk Range | 5.27 - 16.65 |
Market Cap | $792.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 18.23% |
Days to Cover | 36.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ORIC Pharmaceuticals (NASDAQ:ORIC) through any online brokerage.
Other companies in ORIC Pharmaceuticals’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Replimune Group (NASDAQ:REPL), Tango Therapeutics (NASDAQ:TNGX) and Mesoblast (NASDAQ:MESO).
ORIC Pharmaceuticals has a consensus price target of $19.44.
The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $11.24 last updated September 23, 2024 at 4:26 AM EDT.
There are no upcoming dividends for ORIC Pharmaceuticals.
ORIC Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for ORIC Pharmaceuticals.
ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.